Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Cytiva rProtein A Sepharose™ Fast Flow Affinity Media

Catalog No. p-4591510
Click to view available options
Quantity:
5 mL
25 mL
200 mL
Binding Capacity:
50 mg Human lgG/mL
50 mg Human lgG/mL medium2

Designed for purification of monoclonal and polyclonal antibodies at labs and process scales

  • Composed of recombinant protein A coupled with cross-linked 4% agarose base matrix
  • High dynamic binding capacity, single-point attachment of protein A, with high recovery, high purity and low ligand leakage
  • No mammalian components involved during manufacturing process
  • Matrix: 4% cross-linked agarose
  • Average particle size: 90μm (d50V)
  • Ligand: 6mg rProtein A/mL medium (E. coli)
  • Binding capacity: ∽50mg human IgG/mL media
  • pH stability working range: 3 to 10
  • Pressure/Flow specification: base matrix 150 to 250cm/hr., 100kPa, XK 50/60 column, bed
TRUSTED_SUSTAINABILITY

Specifications

Quantity 25 mL
For Use With (Application) For PurifiCatIon of Monoclonal and Polyclonal Antibodies at Labs and Process Scales
Stability Stable in aqueous Buffers commonly used in Protein A Chromatography
Storage Requirements 2°C to 8°C
Binding Capacity 50 mg Human lgG/mL
Product Type rProtein A Sepharose Fast Flow Media
Flow Rate 150 to 250 cm/Hoμr
Particle Size 60 to 165 μm
Height (English) Bed 9.84 in.
Height (Metric) Bed 25 cm
Max. Pressure 100 kPa
Matrix 4% Cross-Linked Agarose
pH Range 2 to 9
Storage Buffer 20% Ethanol
Ligand Type Recombinant Protein A (E. coli)
Show More Show Less
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.